Reports Q4 preliminary unaudited net product revenue approximately $28.3M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AUPH:
- Biotech Alert: Searches spiking for these stocks today
- Aurinia worth ‘keeping closer eye on’ after settlement, Dealreporter says
- AUPH Blasts Up after Settlement is Reached
- Aurinia price target raised to $11 from $10 at RBC Capital
- Aurinia Pharmaceuticals enters patent settlement pact with Sun Pharmaceutical